The European Commission has published a document about biosimilar medicines titled 'What you need to know about Biosimilar Medicinal Products – A consensus information document'.
The document developed as part of the 'Platform on Access to Medicines in Europe' under the 'Process on Corporate Responsibility in the field of Pharmaceuticals'.
It has been prepared by a project group joined by stakeholders from e.g. the pharmaceutical industry, patient organisations and healthcare professionals, by European reimbursement authorities and by the European Commission. The project group was chaired by the Danish Health and Medicines Authority and the European Commission.
For further information, please see the European Commission's Process on Corporate Responsibility in the field of Pharmaceuticals. Here you will also find information about the project group on biosimilar medicinal products.